- Title
- A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease
- Creators
- K KieburtzG B LandwehrmeyerM CudkowiczE R DorseyA FeiginV HuntE KaysonM McDermottS NoonbergW SeitzP SoliveriF WalkerJ M BurgunderI RomeroA MagaraY SteblerH RickardsJ WrightJ De SouzaR A BarkerS MasonA GoodmanD O'KeeffeM LangloisG FerlandL VerretS ChouinardS ParisC LePageA H NemethC MerrittC CoxT AstburyS MurphyA AhmedP St MarieR A BerilaC KubuV SegroR KumarD EricksonJ SchneidersS FruchtP WassermanB ScottP Perry-TriceS WyneD ParidaV RedaelliW SoltanP RobowskiM NowakM SchinwelskiA DziadkiewiczT AndrewsD RuddyA DoughertyK BoelmansJ SchmalfeldA MunchauS ZittelW MalloneeG SuterJ TanL SeebergerJ HarrisJ ChampionJ WojcieszekJ BeldenK PriceM Hughes-GayG SprehnF SquitieriT MartinoF De GregorioA De NicolaF ElifaniA RosenblattN YoritomoR MargolisP NicholsS E PalhagenA V HoglundM Paucar - Karolinska InstitutetT W Reza-SoltaniA BeisterT RaabJ KieniC SchrenkK BanaszkiewiczJ MisztelaM WojcikE SzczygielM GoloszM RudzinskaRAC RoosSJA van den BogaardR BosS J BooijC HysonJ MegensE MakajiM JenkinsS HerschS MayaC DresserD RosasK BlindauerC SchindlerS HungA A McNeesS TabriziM NovakM SayA PatelP PanegyresS JukichC FaullL E HjermindO JakobsenA VogelT R NielsenJ E NielsenS KostykA SewardP AgrawalJ KraakevikP HogarthA WilsonJ LearP H KrausC SaftT SteinerR HoffmannC StammJ SchollhammerI UhlB KaminskiK O'DonovanO QuarrellL NevittC KippsA HareK GunnerE HaywardM NanceJ HamerlinckC WielinskiO YastrubetskayaE ChiuP ChuaB MannaaM de TommasoC SerpinoC CormioV SciruicchioG De MicheleL Di MaioF SaccaE SalvatoreT TucciM WolzL KlingelhoferA WolzS SchmidtA StorchE SpruthS ThielB NeumannH GelderblomJ PrillerC SassD ProbstC WernerB R LeavittA ColemanL RaymondV WheelockT TempkinK BaynesN HermanowiczS NiswongerM Haske-PalominoY BordelonA GratianoA JohnsonJ Corey-BloomJ GoldsteinG PeavyM GeschwindJ GooblarC BartonH FernandezM SuelterM DanielsJ RomrellC SwartzL BeglingerE EppingE WatermanM M SmithR DubinskyH DubinskyC GrayD CraufurdE HowardM JonesH MurphyK AndersonC NickersonJ De SantoT RigaudN ZappalaB RobottomC SingerM QuesadaK Rodriguez-SpenglerR H CardenacheR ReilmannS BohlenE M HoelznerA ColcherH MaccaroneL AltinA SiderowfT J GreenamyreN LucarelliL IvancoF MarshallC HickeyL DeuelK BiglanS D SussmuthM OrthS TrautmannC EschenbachA SamiiA MacaraegD ZielonkaA CiesielskaJ T MarcinkowskiJ SempolowiczH KaraskiewiczC O'NeillI HaqG WitkowskiJ AntczakR RolaP RichterM RakowiczK JachinskaS CriswellP DeppenK WhartonN MahantE McCuskerJ GriffithC LoyL StewartD FisherD HoltC OrmeA WattsJ WeberK WhiteR A HauserR AlbinC CoffeyW FischerJ MiyasakiCarol MoskowitzNicola LewisCinzia RussoHORIZON Investigators
- Publication Details
- JAMA neurology, Vol.70(1), pp.25-33
- Academic Unit
- Miller School of Medicine; UMMG Department of Neurology
- Language
- English
- Resource Type
- Journal article
- PMID
- 23108692
- Record Identifier
- 991031599908302976
Journal article
A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease
JAMA neurology, Vol.70(1), pp.25-33
2013
PMID: 23108692
Metrics
11 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.52 Neurodegenerative Diseases
- 1.52.951 Huntington's Disease
- Web Of Science research areas
- Clinical Neurology
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites